OMEPRAZOLE MAGNESIUM, AMOXICILLIN AND RIFABUTIN

OMEPRAZOLE MAGNESIUM, AMOXICILLIN AND RIFABUTIN was reported 219 times

These side effects are most commonly reported by patients taking OMEPRAZOLE MAGNESIUM, AMOXICILLIN AND RIFABUTIN:

# Side effect Count
0 DRUG INEFFECTIVE 32
1 RASH 25
2 TREATMENT FAILURE 21
3 HEADACHE 18
4 NAUSEA 18
5 DIARRHOEA 16
6 FATIGUE 16
7 PAIN 11
8 VOMITING 11
9 ABDOMINAL PAIN 10
10 DIZZINESS 10
11 PRURITUS 9
12 ABDOMINAL PAIN UPPER 8
13 DYSPEPSIA 8
14 PYREXIA 8
15 INSOMNIA 7
16 CHROMATURIA 6
17 ERYTHEMA 6
18 INCORRECT DOSE ADMINISTERED 6
19 URTICARIA 6
20 WEIGHT DECREASED 6
21 ABDOMINAL DISCOMFORT 5
22 ASTHENIA 5
23 DECREASED APPETITE 5
24 GASTROOESOPHAGEAL REFLUX DISEASE 5
25 MIGRAINE 5
26 MYALGIA 5
27 ABDOMINAL DISTENSION 4
28 ADVERSE DRUG REACTION 4
29 ARTHRALGIA 4
30 BACK PAIN 4
31 CHEST PAIN 4
32 CHILLS 4
33 CLOSTRIDIUM DIFFICILE INFECTION 4
34 HELICOBACTER INFECTION 4
35 HYPERSENSITIVITY 4
36 PERIPHERAL SWELLING 4
37 RASH PRURITIC 4
38 TOOTH DISCOLOURATION 4
39 VITREOUS FLOATERS 4
40 WEIGHT INCREASED 4
41 CONDITION AGGRAVATED 3
42 COUGH 3
43 DEHYDRATION 3
44 DYSPHAGIA 3
45 DYSPNOEA 3
46 EYE PAIN 3
47 FEELING ABNORMAL 3
48 FEELING HOT 3
49 FLATULENCE 3
50 FUNGAL INFECTION 3
51 GENERAL PHYSICAL HEALTH DETERIORATION 3
52 HYPERTENSION 3
53 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3
54 NASAL CONGESTION 3
55 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3
56 UNEVALUABLE EVENT 3
57 VISION BLURRED 3
58 ACUTE KIDNEY INJURY 2
59 BEDRIDDEN 2
60 BLINDNESS UNILATERAL 2
61 BRONCHIECTASIS 2
62 CONTRAINDICATED PRODUCT PRESCRIBED 2
63 CORONARY ARTERY DISEASE 2
64 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2
65 DRY MOUTH 2
66 FEEDING DISORDER 2
67 GASTRIC ULCER 2
68 GASTRITIS 2
69 GASTROINTESTINAL DISORDER 2
70 GLOSSITIS 2
71 GOUT 2
72 HYPERKALAEMIA 2
73 HYPERLIPIDAEMIA 2
74 IMMUNE SYSTEM DISORDER 2
75 INFECTION 2
76 LEFT VENTRICULAR HYPERTROPHY 2
77 LETHARGY 2
78 LEUKOPENIA 2
79 LIMB INJURY 2
80 LIP SWELLING 2
81 MALAISE 2
82 MEMORY IMPAIRMENT 2
83 MULTIPLE SCLEROSIS 2
84 MUSCLE SPASMS 2
85 OFF LABEL USE 2
86 OPEN ANGLE GLAUCOMA 2
87 PAIN IN EXTREMITY 2
88 PHARYNGEAL SWELLING 2
89 PHOTOPSIA 2
90 PRODUCT DOSE OMISSION ISSUE 2
91 PULMONARY MASS 2
92 RASH ERYTHEMATOUS 2
93 RIGHT VENTRICULAR FAILURE 2
94 SKIN BURNING SENSATION 2
95 SLEEP DISORDER 2
96 SOMNOLENCE 2
97 SYNCOPE 2
98 THERAPY CESSATION 2
99 TONGUE DISCOLOURATION 2
100 TREATMENT NONCOMPLIANCE 2
101 TREMOR 2
102 TRICUSPID VALVE INCOMPETENCE 2
103 UNDERDOSE 2
104 VISUAL IMPAIRMENT 2
105 ACCIDENTAL OVERDOSE 1
106 ANAEMIA 1
107 ANAPHYLACTIC REACTION 1
108 ATRIAL FIBRILLATION 1
109 BACTERIAL ABDOMINAL INFECTION 1
110 BALANCE DISORDER 1
111 BLOOD LOSS ANAEMIA 1
112 BLOOD PRESSURE INCREASED 1
113 BLOOD TRIGLYCERIDES INCREASED 1
114 BLOOD URINE PRESENT 1
115 BONE PAIN 1
116 BOWEL MOVEMENT IRREGULARITY 1
117 BURNING MOUTH SYNDROME 1
118 BURNING SENSATION 1
119 CARDIAC DYSFUNCTION 1
120 CARDIAC FAILURE 1
121 CARDIAC FLUTTER 1
122 CARDIAC VALVE DISEASE 1
123 CARDIOMYOPATHY 1
124 CATARACT 1
125 CHEST DISCOMFORT 1
126 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1
127 COLITIS 1
128 CONFUSIONAL STATE 1
129 CONTRAINDICATED PRODUCT ADMINISTERED 1
130 CORONARY ARTERIAL STENT INSERTION 1
131 COVID-19 1
132 DERMATITIS ALLERGIC 1
133 DEVICE PHYSICAL PROPERTY ISSUE 1
134 DIPLOPIA 1
135 DISCOLOURED VOMIT 1
136 DISCOMFORT 1
137 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1
138 DRUG ERUPTION 1
139 DRUG HYPERSENSITIVITY 1
140 DYSGEUSIA 1
141 DYSPNOEA EXERTIONAL 1
142 EOSINOPHIL COUNT DECREASED 1
143 EPISTAXIS 1
144 ERUCTATION 1
145 EXPIRED PRODUCT ADMINISTERED 1
146 EYE SWELLING 1
147 FAECES SOFT 1
148 FALL 1
149 FLUSHING 1
150 FOREIGN BODY IN THROAT 1
151 GAIT DISTURBANCE 1
152 GENITAL BURNING SENSATION 1
153 GENITAL HYPOAESTHESIA 1
154 HAEMATURIA 1
155 HAEMORRHOIDS 1
156 HALLUCINATION 1
157 HEART FAILURE WITH PRESERVED EJECTION FRACTION 1
158 HEART RATE INCREASED 1
159 HELICOBACTER TEST POSITIVE 1
160 HEPATIC CANCER 1
161 HEPATIC ENZYME INCREASED 1
162 HICCUPS 1
163 HOSPITALISATION 1
164 HUNGER 1
165 HYPERTRANSAMINASAEMIA 1
166 HYPERVOLAEMIA 1
167 HYPOAESTHESIA 1
168 HYPOAESTHESIA ORAL 1
169 HYPOKINESIA 1
170 HYPOTENSION 1
171 IMPAIRED DRIVING ABILITY 1
172 INABILITY TO AFFORD MEDICATION 1
173 INFLAMMATION 1
174 INFLUENZA LIKE ILLNESS 1
175 INJURY 1
176 INTENTIONAL PRODUCT MISUSE 1
177 JAUNDICE 1
178 LIBIDO INCREASED 1
179 LIMB DISCOMFORT 1
180 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1
181 MALNUTRITION 1
182 MELAENA 1
183 MONOCYTE COUNT DECREASED 1
184 MUSCLE SWELLING 1
185 MYOCARDIAL INFARCTION 1
186 MYOPATHY 1
187 NASOPHARYNGITIS 1
188 NEPHROLITHIASIS 1
189 NEURALGIA 1
190 NEUROPATHY PERIPHERAL 1
191 NEUTROPENIA 1
192 NEUTROPHIL COUNT DECREASED 1
193 OCULAR DISCOMFORT 1
194 OESOPHAGEAL SPASM 1
195 OPTIC ISCHAEMIC NEUROPATHY 1
196 ORAL CANDIDIASIS 1
197 ORAL MUCOSAL DISCOLOURATION 1
198 ORAL MUCOSAL ERUPTION 1
199 OROPHARYNGEAL DISCOMFORT 1
200 OROPHARYNGEAL PAIN 1
201 OVERDOSE 1
202 PAIN OF SKIN 1
203 PALPITATIONS 1
204 PARAESTHESIA 1
205 PARAESTHESIA ORAL 1
206 PARANASAL SINUS HYPERSECRETION 1
207 PELVIC FRACTURE 1
208 PLATELET COUNT DECREASED 1
209 PNEUMOTHORAX 1
210 POOR QUALITY SLEEP 1
211 PORTAL HYPERTENSIVE GASTROPATHY 1
212 PRESCRIBED UNDERDOSE 1
213 PRODUCT ADMINISTRATION ERROR 1
214 PRODUCT INEFFECTIVE 1
215 PRODUCT PACKAGING QUANTITY ISSUE 1
216 PRODUCT USE IN UNAPPROVED INDICATION 1
217 PRODUCT USE ISSUE 1
218 PRODUCTIVE COUGH 1
219 PROSTATIC SPECIFIC ANTIGEN INCREASED 1
220 RASH PAPULAR 1
221 RENAL FAILURE 1
222 RENAL TUBULAR NECROSIS 1
223 RESPIRATORY DISORDER 1
224 RESTLESS LEGS SYNDROME 1
225 RHEUMATOID ARTHRITIS 1
226 RIB FRACTURE 1
227 SKELETAL INJURY 1
228 SKIN DISCOLOURATION 1
229 SKIN HAEMORRHAGE 1
230 SKIN IRRITATION 1
231 SKIN WARM 1
232 SOMNAMBULISM 1
233 STOMATITIS 1
234 SWELLING FACE 1
235 SWOLLEN TONGUE 1
236 TACHYCARDIA 1
237 TASTE DISORDER 1
238 THROAT IRRITATION 1
239 TONGUE DISCOMFORT 1
240 TONGUE DISORDER 1
241 TONGUE ERYTHEMA 1
242 TOXICITY TO VARIOUS AGENTS 1
243 UPPER-AIRWAY COUGH SYNDROME 1
244 URINE ABNORMALITY 1
245 VAGINAL INFECTION 1
246 VASCULAR DEVICE INFECTION 1
247 VASODILATATION 1
248 VULVOVAGINAL DISCOMFORT 1
249 VULVOVAGINAL PRURITUS 1
250 WHITE BLOOD CELL COUNT DECREASED 1
251 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1
252 YELLOW SKIN 1